Effect of Arterial Cannulation on the Continuous and Non-invasive Hemoglobin Monitoring
1 other identifier
interventional
44
1 country
1
Brief Summary
The primary purpose of this study is to investigate the effect of arterial cannulation on the continuous and non-invasive hemoglobin monitoring during laparoscopic gastrectomy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable gastric-cancer
Started May 2019
Shorter than P25 for not_applicable gastric-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 14, 2019
CompletedFirst Submitted
Initial submission to the registry
May 17, 2019
CompletedFirst Posted
Study publicly available on registry
May 21, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 26, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 26, 2019
CompletedMay 11, 2021
May 1, 2021
1 month
May 17, 2019
May 9, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
difference between SpHb value and SaHb value (SpHb - SaHb) in g/dL
SpHb value (g/dL) is measured by co-oxymetry, and SaHb value (g/dL) is measured by blood sampling.
3 time points from the start of anesthesia to the end of anesthesia, an average 2 hours
Study Arms (2)
Same group
EXPERIMENTALarterial cannulation on same arm of continuous hemoglobin monitoring
Different group
PLACEBO COMPARATORarterial cannulation on different arm of continuous hemoglobin monitoring
Interventions
arterila cannulation on same arm receiving continous hemoglobin monitoring
arterila cannulation different arm receiving continous hemoglobin monitoring
Eligibility Criteria
You may qualify if:
- Laparoscopic gastrectomy under general anesthesia
You may not qualify if:
- atypical hemoglobin disease, infective state, cardiovascular disease, peripheral vascular disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Anesthesiology and Pain Medicine, Ajou University School of Medicine
Suwon, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor
Study Record Dates
First Submitted
May 17, 2019
First Posted
May 21, 2019
Study Start
May 14, 2019
Primary Completion
June 26, 2019
Study Completion
June 26, 2019
Last Updated
May 11, 2021
Record last verified: 2021-05